RVX Insider Trading

Insider Ownership Percentage: 42.66%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$1,500.00

Resverlogix Insider Trading History Chart

This chart shows the insider buying and selling history at Resverlogix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025C$0boughtC$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-C$20kC$0C$20kTotal Insider BuyingTotal Insider Selling

Resverlogix Share Price & Price History

Current Price: C$0.05
Price Change: Price Decrease of -0.005 (-9.09%)
As of 01/21/2025 03:06 PM ET

This chart shows the closing price history over time for RVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJanC$0.05Closing price on 01/21/25:

Resverlogix Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Resverlogix (TSE:RVX)

Resverlogix logo
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More on Resverlogix

Today's Range

Now: C$0.05
Low: C$0.05
High: C$0.06

50 Day Range

MA: C$0.06
Low: C$0.05
High: C$0.06

52 Week Range

Now: C$0.05
Low: C$0.04
High: C$0.10

Volume

117,100 shs

Average Volume

63,163 shs

Market Capitalization

C$13.85 million

P/E Ratio

N/A

Dividend Yield

7.02%

Beta

0.71

Who are the company insiders with the largest holdings of Resverlogix?

Resverlogix's top insider investors include:
  1. Aaron Bradley Cann (Senior Officer)
Learn More about top insider investors at Resverlogix.